Advanced cervical cancer: pembrolizumab prolongs life

IQWiG

2 November 2022 - There is a hint of a major added benefit compared to chemotherapy with cisplatin or carboplatin, each plus paclitaxel with or without bevacizumab. 

These are the main first-line therapies for advanced cervical cancer.

Read IQWiG press release [German]

Michael Wonder

Posted by:

Michael Wonder